PIERS proteinuria: relationship with adverse maternal and perinatal outcome.
Payne B, Magee LA, Côté AM, Hutcheon JA, Li J, Kyle PM, Menzies JM, Peter Moore M, Parker C, Pullar B, von Dadelszen P, Walters BN; PIERS Study Group (Appendix); von Dadelszen P, Magee LA, Douglas MJ, Walley KR, Russell JA, Lee SK, Gruslin A, Smith GN, Côté AM, Moutquin JM, Brown MA, Davis G, Walters BN, Sass N, Duan T, Zhou J, Mahajan S, Noovao A, McCowan LA, Kyle P, Moore MP, Bhutta SZ, Bhutta ZA, Hall, Steyn DW, Broughton Pipkin F, Loughna P, Robson S, de Swiet M, Walker JJ, Grobman WA, Lindheimer MD, Roberts JM, Mark Ansermino J, Benton S, Cundiff G, Hugo D, Joseph KS, Lalji S, Li J, Lott P, Ouellet AB, Shaw D, Keith Still D, Tawagi G, Wagner B, Biryabarema C, Mirembe F, Nakimuli A, Tsigas E, Merialdi M, Widmer M.
Payne B, et al. Among authors: benton s.
J Obstet Gynaecol Can. 2011 Jun;33(6):588-597. doi: 10.1016/S1701-2163(16)34907-6.
J Obstet Gynaecol Can. 2011.
PMID: 21846448
METHODS: We performed a prospective multicentre cohort study, PIERS (Preeclampsia Integrated Estimate of RiSk), in seven academic tertiary maternity centres practising expectant management of preeclampsia remote from term in Canada, New Zealand, and Australia. Eligible wom …
METHODS: We performed a prospective multicentre cohort study, PIERS (Preeclampsia Integrated Estimate of RiSk), in seven academic tertiary m …